IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $279 | -9.4% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $308 | +1.0% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $305 | -15.0% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $359 | -99.9% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $300,000 | -10.2% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $334,000 | -8.2% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $364,000 | +7.7% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $338,000 | -10.6% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $378,000 | +1.3% | 28,955 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $373,000 | +23.5% | 28,955 | +7.0% | 0.00% | 0.0% |
| Q1 2021 | $302,000 | -1.9% | 27,055 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $308,000 | +26.7% | 27,055 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $243,000 | -56.5% | 27,055 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $558,000 | – | 54,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |